# Activation and Cell Death of Mouse Eosinophils in Response to Different Microenvironmental Stimuli

**Authors:** Immaculeta Osuji, Nives Zimmermann

PMC · DOI: 10.3390/cells15060490 · Cells · 2026-03-10

## TL;DR

This study explores how mouse eosinophils respond to various inflammatory signals by activating different cell death pathways, revealing distinct patterns of activation and death.

## Contribution

The study identifies at least three distinct activation-associated cell death pathways in eosinophils triggered by microenvironmental stimuli.

## Key findings

- CD95 crosslinking induces apoptosis and type 2 activation in eosinophils.
- PMA causes EETosis and type 2 activation in eosinophils.
- LPS/zVAD leads to type 1 activation and a novel cell death subtype.

## Abstract

In inflammatory states, eosinophils are exposed to stimuli leading to activation, increased survival, and/or different cell death subroutines, which have differing effects on tissue inflammation. The mechanisms of signal integration are poorly understood. In this manuscript, we investigated cell death types in response to stimuli mimicking the inflammatory microenvironment. Mouse bone marrow-derived eosinophils (BMDeos) were stimulated with cytokines, cell-cell interaction mimics, pathogen-associated molecular patterns (PAMP), and broad cell activation stimuli. Both PMA and crosslinking of CD95 (cCD95) induced cell death of BMDeos. However, cCD95-induced cell death was consistent with apoptosis, while activation with PMA lead to EETosis. Both stimuli lead to caspase 3 activation and increased total level of histone H3 citrullination, indicating that these outcomes are not able to discriminate between the two cell death types. Flow cytometry for annexinV/7AAD pattern at early time points, and morphologic assessment by immunofluorescence (for DNA, eosinophil granule protein and citH3) were the most reliable outcomes for distinguishing the cell death subtypes. While LPS alone did not decrease BMDeos viability, LPS in the presence of caspase inhibition (zVAD) caused delayed cell death, which did not conform to either of the two cell death types. Finally, LPS and LPS/zVAD led to an increased level of surface expression of CD274 (type 1 activation), while both cCD95 and PMA increased the surface expression of CD101 (type 2 activation). In summary, at least three different activation-associated cell death pathways are seen in BMDeos activated with microenvironment-mimicking stimuli. Crosslinking CD95 leads to type 2 activation and apoptotic cell death. PMA also leads to type 2 activation but EETosis-associated cell death. LPS and LPS/zVAD are associated with type 1 activation, and only LPS/zVAD lead to cell death via a subtype different from both apoptosis and EETosis.

## Linked entities

- **Proteins:** FAS (Fas cell surface death receptor), CD274 (CD274 molecule), CD101 (CD101 molecule), Casp3 (caspase 3)
- **Chemicals:** PMA (PubChem CID 171116383), zVAD (PubChem CID 9845918)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Ccr3 (C-C motif chemokine receptor 3) [NCBI Gene 12771] {aka CC-CKR3, CKR3, Cmkbr1l2, Cmkbr3}, Fcgr2b (Fc receptor, IgG, low affinity IIb) [NCBI Gene 14130] {aka CD32, F630109E10Rik, Fc[g]RII, FcgRII, Fcgr2, Fcgr2a}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Fas (Fas cell surface death receptor) [NCBI Gene 14102] {aka APO1, APT1, CD95, TNFR6, Tnfrsf6, lpr}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, pma (peroneal muscular atrophy) [NCBI Gene 18849], Cd101 (CD101 antigen) [NCBI Gene 630146] {aka EWI-101, Gm1016, Gm734, Igsf2}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, Mbp (myelin basic protein) [NCBI Gene 17196] {aka Hmbpr, golli-mbp, jve, mld, shi}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Epcam (epithelial cell adhesion molecule) [NCBI Gene 17075] {aka CD326, EGP, EGP-2, Egp314, Ep-CAM, EpCAM1}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Fasl (Fas ligand) [NCBI Gene 14103] {aka APT1LG1, CD178, CD95-L, CD95L, Fas-L, Faslg}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, FLT3 (fms related receptor tyrosine kinase 3) [NCBI Gene 2322] {aka CD135, FLK-2, FLK2, STK1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}
- **Diseases:** helminthic infections (MESH:D007239), injury to (MESH:D014947), bacterial infection (MESH:D001424), EADs (MESH:D017681), EGIDs (MESH:D005767), EoE (MESH:D057765), cancer (MESH:D009369), tissue (MESH:D017695), fibrosis (MESH:D005355), atopic dermatitis (MESH:D003876), colitis (MESH:D003092), Necrosis (MESH:D009336), asthma (MESH:D001249), allergic airway inflammation (MESH:D007249), allergic diseases (MESH:D004342)
- **Chemicals:** BMDeos (-), streptomycin (MESH:D013307), L-glutamine (MESH:D005973), Triton X 100 (MESH:D017830), FITC (MESH:D016650), DAPI (MESH:C007293), HEPES (MESH:D006531), phorbol 12-myristate 13-acetate (MESH:D013755), Alexa Fluor 488 (MESH:C000711379), phosphatidyl serine (MESH:D010718), 7-AAD (MESH:C025942), formalin (MESH:D005557), BD (MESH:C028491), amino acids (MESH:D000596), PBS (MESH:D007854), penicillin (MESH:D010406), LPS (MESH:D008070), ATP (MESH:D000255), mepolizumab (MESH:C434107), Bis-Tris (MESH:C026272), DTT (MESH:D004229)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** BMDeos — Homo sapiens (Human), Finite cell line (CVCL_6F32)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024791/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024791/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024791/full.md

---
Source: https://tomesphere.com/paper/PMC13024791